etoposide vp16, etoposide
Features: chemotherapy drug
Description: <p><b>Etoposide (VP-16)</b> — Conventional cytotoxic chemotherapy drug and semisynthetic podophyllotoxin derivative that inhibits DNA topoisomerase II. Etoposide stabilizes the transient DNA-topoisomerase II cleavage complex, preventing religation of cleaved DNA strands and causing accumulation of DNA strand breaks, inhibition of DNA replication and transcription, cell-cycle arrest, and apoptotic cell death.</p>
<p><b>Drug class:</b> Conventional chemotherapy / Topoisomerase II inhibitor / Podophyllotoxin derivative.</p>
<p><b>Primary mechanism:</b> Topoisomerase II inhibition → DNA strand breaks ↑ → DNA replication and transcription ↓ → DNA damage response ↑ → G2/S-phase cell-cycle arrest ↑ → apoptosis ↑.</p>
<p><b>Typical target/pathway effects:</b> TOP2A/TOP2B inhibition; DNA double-strand breaks ↑; DNA damage ↑; γH2AX ↑; G2 arrest ↑; replication ↓; proliferation ↓; caspase activation ↑; apoptosis ↑.</p>
<p><b>Cancer relevance:</b> Strong. Etoposide is an established cytotoxic anticancer drug used in multiple chemotherapy regimens, particularly for small-cell lung cancer, testicular germ-cell tumors, lymphomas, leukemias, and selected pediatric and solid tumors.</p>